Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2021-09-22 17:55:14
Oslo/London - September 22nd 2021: EXACT Therapeutics AS ('EXACT-Tx') announces
its interim results for the first half 2021. The Interim Report for half year
2021 is also available on the company's website: https://www.exact-tx.com
About EXACT-Tx
EXACT-Tx is a clinical stage Norwegian biotech company developing a technology
platform for targeted therapeutic enhancement - Acoustic Cluster Therapy (ACT®).
ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug
enhancement - with the potential to significantly amplify the clinical utility
of a wide range of therapeutic agents across a multitude of indications
including within oncology (chemotherapy, immunotherapy), infectious diseases,
and neurological conditions. www.exact-tx.com
For more information contact:
Dr Rafiq Hasan, CEO EXACT Therapeutics
Rafiq@exact-tx.com